BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
31 – 40 of 3090
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Tuning the protein phosphorylation by receptor type protein tyrosine phosphatase epsilon (PTPRE) in normal and cancer cells
(
- Contribution to journal › Article
-
Mark
Statin use and breast cancer survival - A Swedish nationwide study
(
- Contribution to journal › Article
-
Mark
Intravesical therapy - BCG and beyond
(
- Contribution to journal › Article
-
Mark
Prognostic Impact of Tumor Cell Programmed Death Ligand 1 Expression and Immune Cell Infiltration in NSCLC
(
- Contribution to journal › Article
-
Mark
EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLC
(
- Contribution to journal › Article
-
Mark
Medical therapy versus transurethral resection of the prostate (TURP) for the treatment of symptomatic benign prostatic enlargement (BPE) : a cost minimisation analysis
(
- Contribution to journal › Article
-
Mark
All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma
(
- Contribution to journal › Article
-
Mark
Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer—an European consensus statement and expert recommendations
(
- Contribution to journal › Article
-
Mark
Aspects of Phagocyte Function in Multiple Myeloma
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Haem iron intake and risk of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
(
- Contribution to journal › Article